Soluble TNF-α receptors are constitutively shed and downregulate adhesion molecule expression in malignant gliomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 5, 1997, Pages 541-550

  Chen, Thomas C ^a   Hinton, David R ^a   Sippy, Brian D ^a   Hofman, Florence M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HMR 312 ^*  (United States)

Author keywords

Adhesion; Gliomas; ICAM 1; Soluble TNF receptors; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030862206     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199705000-00010     Document Type: Article

References (37)

1. Chung IY, Benveniste EN. Tumor necrosis factor-α production by astrocytes: Induction by lipopolysaccharide, IFN-g, and IL-1B. J Immunol 1990;144:2999-3007
2. Roessler K, Suchanek G, Breitschopf H, et al. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: Comparison of immunohistochemistry with in situ hybridization using molecular probes. J Neurosurg 1995;83:291-97
3. Chen TC, Hinton DR, Apuzzo MLJ, Hofman FM. Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas. Neurosurgery 1993;32:85-94
4. Rutka JT, Giblin JR, Berens ME, et al. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: Cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int J Cancer 1988;41:573-82
5. Sugarman BJ, Aggarwal BB, Mass PE, Figari IS, Palladino MA, Shepard BM. Recombinant human necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 1985;230:943-45
6. Dembic Z, Loetscher H, Gubler U, et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-37
7. Loetscher H, Pan YCE, Lahm HW, et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990;61:351-59
8. Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 1995;5:392-96
9. Thoma B, Grell M, Pfizenmaier K, Scheurich P. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 1990;172: 1019-23
10. Mackay F, Loetscher H, Steuber D, Gehr G, Lesslauer W. Tumor necrosis factor alpha (TNF-a)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993;177:1277-86
11. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. A novel domain within the 55 kD TNF receptor signals cell death. Cell 1993;74:845-53
12. Wong GHW, Tartaglia LA, Lee MS, Goeddel DV. Antiviral activity of tumor necrosis factor (TNF) is signaled through the 55-kDa receptor, type I TNF. J Immunol 1992;149:3350-53
13. Wong GHW, Goeddel DV. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 1994;152:1751-55
14. Grell M, Douni E, Wajant H, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802
15. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: T75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;68:18542-48
16. Heller RA, Song K, Fan N, Chang DJ. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992;70:47-56
17. Tartaglia LA, Goeddel DV, Reynolds C, et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 1993;151:4637-41
18. Schneider JS, Hofman FM, Apuzzo MLJ, Hinton DR. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 1992;77:265-73
19. Sippy BD, Hofman FM, Wallach D, Hinton DR. Increased expression of tumor necrosis factor-α receptors in the brains of patients with AIDS. J Acquired Immune Def Syndrome 1995;10:511-21
20. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989: 18.60-18.71
21. Shrikant P, Weber T, Jilling T, Benveniste EN. Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J Immunol 1995;155:1489-1501
22. Rosenman SJ, Shrikant P, Dubb L, Benveniste EN, Ransohoff RM. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 1995;154:1888-99
23. Sippy BD, Hofman FM, He S, et al. SV-40 immortalized and primary cultured human retinal pigment epithelial cells share similar patterns of cytokine-receptor expression and cytokine responsiveness. Current Eye Research 1995;14:495-503
24. Mackay F, Rothe J, Bluethmann H, Loetscher H, Lesslauer W. Differential responses of fibroblasts from wild-type and TNF-R-55-deficient mice to mouse and human TNF-α activation. J Immunol 1994;253:5274-84
25. Neumann, B, Machleidt T, Lifka A, et al. Crucial role of 55-kilo-dalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 1996;156:1587-93
26. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to hmogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-80
27. Neuner P, Klosner G, Poumojib M, Trautinger F, Knobler R. Selective release of tumor necrosis factor binding protein II by malignant epidermal cells reveals protection from tumor necrosis factor alphamediated cytotoxicity. Cancer Res 1994;54:6001-5
28. Aderka D, Engelmann H, Hornik V, et al. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991;51:5602-7
29. Godfried MH, van der Poll T, Jansen J, et al. Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection. AIDS 1993;7:33-36
30. Tada M, Diserens AC, Desbaillets I, de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 1994;80:1063-73
31. Ioli G, Yamamoto R, Jacques D, Neal J, Granger G. Blocking factors (soluble receptors) for human TNF and LT in the serum, cerebrospinal fluid (CSF), and tumor cyst fluid (TCF) of human glioma patients (Meeting Abstract). Proceedings/Annual meeting of the American Association for Cancer Research 1992;33:A1844
32. Slowik MR, de Luca LG, Fiers W, Pober JS. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 1993;143:1724-30
33. Eck MJ, Sprang SR. The structure of tumor necrosis factor alpha at 2.6 A resolution: Implications for receptor binding. J Biol Chem 1989;264:17595-17605
34. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66
35. Kuppner MC, van Meir E, Hamou MF, de Tribolet N. Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expres-sion on human gliomblastoma cells. Clin Exp Immunol 1990;81: 142-48
36. Wenisch C, Varijanonta S, Looareesuwan S, Graninger W, Pichler R, Wernsdorfer W. Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute plasmodium falciparum malaria. Clin Immunol Immunopathol 1994;71:344-48
37. Tsukada N, Matsuda M, Miyagi K, Yaagisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 1993;43:2679-82